IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cellsYosuke Ohno, Akinobu Taketomi, Shigenori Homma et al.|Cancer Immunology Immunotherapy|2016Cited by 116
Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapyYosuke Ohno, Hidemitsu Kitamura, Yujiro Toyoshima et al.|Cancer Science|2017Cited by 85
IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathwayKentaro Sumida, Hidemitsu Kitamura, Yosuke Ohno et al.|Scientific Reports|2015Cited by 31